CM
BIO icon

Capula Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capula Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,287
Closed -$2M – 804
2025
Q2 		$2M Sell
8,287
-819
-9% -$194K 0.02% 136
2025
Q1 		$2.22M Buy
+9,106
New +$2.74M 0.02% 188
2023
Q3 		– Sell
-1,280
Closed -$485K – 517
2023
Q2 		$485K Buy
1,280
+730
+133% +$297K 0.06% 312
2023
Q1 		$263K Sell
550
-1,890
-77% -$885K 0.02% 552
2022
Q4 		$1.03M Buy
2,440
+1,950
+398% +$787K 0.11% 406
2022
Q3 		$204K Buy
+490
New +$244K 0.03% 583

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return